Mobile Menu

Search Results

Search results for: oestrogen

Clinical Trials – What is holding liquid biopsy back?

This feature is written using content from our recently published Liquid Biopsy report, which you can read in full by […]

Liquid biopsy predicts early breast cancer progression

‘Liquid biopsy predicts early breast cancer progression’ – Written by Charlotte Harrison, Science Writer. Researchers from Johns Hopkins University have shown […]

Japanese Study Identifies 35 Genetic Risk Factors for Atrial Fibrillation

In a new study published in Nature, researchers have identified 35 genetic susceptibility loci for atrial fibrillation (AF) in a […]

SNO proteins identified as drivers of Alzheimer’s disease in women

Researchers have unlocked new insights into the molecular mechanism of Alzheimer’s disease (AD), which may explain why women are at […]

CRISPR-Cas9 screening reveals new therapeutic target for aggressive breast cancer 

Researchers at the Virginia Commonwealth University Massey Cancer Center have uncovered a new potential therapeutic target for triple-negative breast cancer […]

Finding biomarkers and mechanisms for chemotherapy resistance in breast cancer

Written by Victoria Lee, Science Writer at Front Line Genomics In the fight against breast cancer, it’s useful to be […]

Hormone Surge Unlocks Sex-Biased Genes

Written by Bethany Hoernfeldt, Science Writer Researchers have found that a neonatal hormone surge triggers a lasting male-biased gene expression […]

Patient Perspectives: Caroline Presho – Director of BRCA Umbrella

Caroline Presho is a mother, motivational speaker and Director of the online platform, BRCA Umbrella. After testing positive for a […]

Genetic signature of treatment resistance in breast cancer identified

Researchers have discovered a genetic signature that can identify drivers of poor outcomes in advanced oestrogen-receptor positive (ER+) breast cancer. […]

Anti-PD-1: The immunotherapy drug that reverses obesity-associated breast cancer

Researchers have discovered that treatment of breast cancer with a checkpoint inhibitor drug, called anti-PD-1, significantly reduces obesity-associated tumour burden. […]